Evidence map›Paper›PMID 35072167›Full record

ArticleCommunications medicine2021

Host methylation predicts SARS-CoV-2 infection and clinical outcome.

Iain R Konigsberg, Bret Barnes, Monica Campbell, Elizabeth Davidson, Yingfei Zhen, Olivia Pallisard, Meher Preethi Boorgula, Corey Cox, Debmalya Nandy, Souvik Seal and 21 more

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 78 citations in OpenAlex.

  1. A Multi-Omic Mosaic Model of Acetaminophen Induced Alanine Aminotransferase Elevation.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2023
    Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 1 country.

Iain R Konigsberg *School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Bret Barnes *Illumina, Inc., San Diego, CA USA.
Monica CampbellSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Elizabeth DavidsonSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Yingfei ZhenSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Olivia PallisardSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Meher Preethi BoorgulaSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Corey CoxSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Debmalya NandyColorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Souvik SealColorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Kristy CrooksSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Evan SticcaSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Genelle F HarrisonSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Andrew HopkinsonSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.ORCID 0000-0003-3394-6196
Alexis VestSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Cosby G ArnoldSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Michael G KahnSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.ORCID 0000-0003-4786-6875
David P KaoSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.ORCID 0000-0002-2832-9348
Brett R PetersonSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Stephen J WicksSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Debashis GhoshColorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Steve HorvathUniversity of California Los Angeles, Los Angeles, CA USA.ORCID 0000-0002-4110-3589
Wanding ZhouThe Children's Hospital of Philadelphia, Philadelphia, PA USA.
Rasika A MathiasSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.ORCID 0000-0002-2282-9042
Paul J NormanSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Rishi PorechaIllumina, Inc., San Diego, CA USA.
Ivana V YangSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Christopher R GignouxSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Andrew A MonteSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.
Alem TayeIllumina, Inc., San Diego, CA USA.
Kathleen C BarnesSchool of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO USA.ORCID 0000-0002-3030-4705
University of Colorado Anschutz Medical Campus · USColorado School of Public Health · USIllumina (United States) · USChildren's Hospital of Philadelphia · USJohns Hopkins University · USUniversity of California, Los Angeles · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Natural Killer cells and the Immunogenetics of COVID-19R01AI158410 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NORMAN, PAUL JOHN · 2021 to 2024
$2.9M
PERSONALIZING EMERGENCY/ACUTE THERAPEUTICS UTILIZING SYSTEMS BIOLOGY (PEGASUS)R35GM124939 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI MONTE, ANDREW ALBERT · 2017 to 2021
$2.1M
A COVID-19 Pulmonary Outcome Clinical Prediction Rule Using EpigeneticsF32HL160123 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ARNOLD, COSBY · 2021 to 2022
$157k
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NHLBI NIH HHS F32 HL160123NIAID NIH HHS R01 AI158410NIGMS NIH HHS R35 GM124939
6 · The paper itself

Abstract

backgroundSince the onset of the SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR

methodsWe customized Illumina's Infinium MethylationEPIC array to enhance immune response detection and profiled peripheral blood samples from 164 COVID-19 patients with longitudinal measurements of disease severity and 296 patient controls.

resultsEpigenome-wide association analysis revealed 13,033 genome-wide significant methylation sites for case-vs-control status. Genes and pathways involved in interferon signaling and viral response were significantly enriched among differentially methylated sites. We observe highly significant associations at genes previously reported in genetic association studies (

conclusionsIn summary, the strong COVID-19-specific epigenetic signature in peripheral blood driven by key immune-related pathways related to infection status, disease severity, and clinical deterioration provides insights useful for diagnosis and prognosis of patients with viral infections.

Indexed as

Predictive markersViral infection

Identifiers

PMID35072167
PMCPMC8767772
OpenAlexW4251254644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.